Eli Lilly’s $7 billion deal for Kelonia Therapeutics on Monday was simply the most recent instance of the sky-high costs that Big Pharmas are prepared to pay for in vivo CAR-T tech. In truth, it was the corporate’s second play for the area this 12 months—having bought Orna Therapeutics for up to $2.4 billion in February. Lilly…
Topline Hims & Hers Health inventory climbed as a lot as 11% Monday, persevering with a week-long rally after the FDA introduced a gathering to talk about easing peptide regulation—a push repeatedly championed by Robert F. Kennedy Jr. (Photo by Alex Wong/Getty Images) Getty Images Key Facts Hims & Hers inventory is up as a…
Eli Lilly is spending $3.25 billion to accumulate Kelonia Therapeutics, a small biotech firm growing cell therapies for most cancers and autoimmune ailments, the businesses introduced Monday. Lilly might pay extra if Kelonia achieves specified scientific, regulatory, and business milestones. The acquisition is a boon for the small startup, which has subsisted on $60 million…
Eli Lilly LLY stays a dominant participant within the international weight problems market, with a lot of its latest development pushed by itsblockbuster tirzepatide (GLP-1) injections, Mounjaro for kind II diabetes (T2D) and Zepbound for weight problems. Despite being in the marketplace for simply over three years, each merchandise have delivered distinctive gross sales development…
Pfizer (NYSE: PFE) traders obtained some very dangerous information when the corporate was compelled to desert its internally developed GLP-1 weight reduction drug in April, 2025. With patent expirations on the horizon, falling even additional behind opponents like Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) in an rising new drug area of interest…
Shares of Eli Lilly (NYSE: LLY) are hovering just under the $900 degree, inserting the corporate amongst high-priced shares the place stock split hypothesis usually builds. While a cut up doesn’t change the basics of the underlying enterprise, it makes the inventory extra liquid and will increase its enchantment to a wider investor base. Stock…